⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 9, 2024Neurology

Safety and Tolerability of Intravenous Immunoglobulin Infusion in Down Syndrome Regression Disorder (P6-8.007)

Jonathan D. Santoro Saba Jafarpour Mellad Khoshnood Natalie K. Boyd Benjamin Vogel Lina Nguyen Michael S. Rafii

View at Publisher

Ask AI

Bookmark

Share

Abstract

This study sought to evaluate the safety and tolerability of IVIg in individuals with DSRD compared to a real-world cohort of individuals with pediatric onset neuroimmunologic disorders.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Santoro et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677dca https://doi.org/10.1212/wnl.0000000000205288

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Immunosuppressive Therapies in Down Syndrome Regression Disorder: A Prospective Observational Cohort Study (N2.002)Cohort Study · 2026
2Immunosuppression in Down syndrome regression disorder: a prospective observational cohort studyCohort Study · 2026
3Evaluating the Safety and Efficacy of Different Intravenous Immunoglobulin 10 Percent Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients (P7-9.008)Late-Phase Clinical Trial · 2026
4A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression DisorderObservational Study · 2026 · 1 citations
5Efficacy and Safety of Intravenous Immunoglobulin in Children with Autism Spectrum Disorder with Immune Dysregulation: A Prospective, Open-Label, Single-Arm StudyBlinded Clinical Trial · 2026

More related papers

Adverse Reactions to Intravenous Immunoglobulin in Children with Primary Immunodeficiencies: A Single Center Experience2026
Case Report: Improvement Following Immunotherapy in an Individual With Seronegative Down Syndrome Disintegrative Disorder2021
Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study2026

More from Neurology

Role of APOE ɛ4 and ɛ2 With Longitudinal Cognitive Decline Among Those With Exceptional LongevityFri,
Associations of Antibodies Against Several Infections With Alzheimer Disease NeuropathologyFri,